marijuana stocks news

Cara Therapeutics to Announce First Quarter 2015 Financial Results on May 12, 2015

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Tuesday, May 12, 2015, at 4:30 p.m. ET to report first quarter 2015 financial results and provide a corporate update.

To participate in the conference call, please dial 855-445-2816 (domestic) or 484-756-4300 (international) and refer to conference ID 41947428. A live webcast of the call can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com.

An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Contact:
Investor Contact
Jesse Baumgartner
Stern Investor Relations
212-362-1200
jesse@sternir.com
Media Contact
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

4Front Ventures Corp. (FFNTF) to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

4Front Ventures to Report Fourth Quarter and Full Year 2022 Financial Results…

PotNetwork Holding, Inc. (POTN) Strategizes to Deliver Results on Strengthened Momentum

PotNetwork Strategizes to Deliver Results on Strengthened Momentum, with over $5 Million…

AbbVie Inc. (ABBV) to Host First-Quarter 2022 Earnings Conference Call

AbbVie to Host First-Quarter 2022 Earnings Conference Call AbbVie (NYSE: ABBV) will…

mCig Inc. (MCIG) Broadens Construction Project Portfolio and Expands Cannabis Supply Division

mCig Broadens Construction Project Portfolio and Expands Cannabis Supply Division to the…